Mucha-Habermann disease: a pediatric case report and proposal of a risk score

Martin Ernst Blohm1,2, Chinedu Ulrich Ebenebe1,2, Cornelius Rau1,2

  • 1Department of Paediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Insights

Febrile ulceronecrotic Mucha-Habermann disease (FUMHD) is rare. A new mortality risk score helps balance treatment intensity against risks like sepsis, especially in adults, guiding better patient outcomes.

Area of Science:

  • Dermatology
  • Immunology
  • Epidemiology

Background:

  • Febrile ulceronecrotic Mucha-Habermann disease (FUMHD) is a severe, rare inflammatory dermatological condition.
  • Understanding FUMHD's epidemiology and risk factors is crucial for effective management.

Observation:

  • A case study of a 13-year-old boy with FUMHD, potentially triggered by Mycoplasma infection, highlights clinical presentation.
  • The patient experienced leukopenia and thrombocytopenia but recovered without systemic immunosuppression.

Findings:

  • Literature review of 119 FUMHD cases revealed an overall lethality of 12%, with significantly higher mortality in adults (20%) than children (2%).
  • Key risk factors for fatal outcomes include sepsis, adult age, systemic involvement, and mucosal involvement.
  • A novel FUMHD mortality risk score was developed, demonstrating high sensitivity (93%) and specificity (77%) in predicting fatal outcomes.

Implications:

  • The proposed FUMHD mortality risk score aids clinicians in tailoring immunosuppressive treatment intensity.
  • Balancing treatment against mortality risks, particularly infectious complications, is vital for improving FUMHD patient survival.
  • Further research into FUMHD triggers, like Mycoplasma infections, could inform preventative strategies.

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
311
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
102
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
591
Hazard Rate01:11

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
227